Gemma L. Zeybel
Ivacaftor and symptoms of extra-oesophageal reflux in patients with cystic fibrosis and G551D mutation
Zeybel, Gemma L.; Pearson, Jeffrey P.; Krishnan, Amaran; Bourke, Stephen J.; Doe, Simon; Anderson, Alan; Faruqi, Shoaib; Morice, Alyn H.; Jones, Rhys; McDonnell, Melissa; Zeybel, Mujdat; Dettmar, Peter W.; Brodlie, Malcolm; Ward, Chris
Authors
Jeffrey P. Pearson
Amaran Krishnan
Stephen J. Bourke
Simon Doe
Alan Anderson
Shoaib Faruqi
Professor Alyn Morice A.H.Morice@hull.ac.uk
Foundation Chair and Professor of Respiratory Medicine
Rhys Jones
Melissa McDonnell
Mujdat Zeybel
Peter W. Dettmar
Malcolm Brodlie
Chris Ward
Abstract
© 2016 The Authors Background Extra-oesophageal reflux (EOR) may lead to microaspiration in patients with cystic fibrosis (CF), a probable cause of deteriorating lung function. Successful clinical trials of ivacaftor highlight opportunities to understand EOR in a real world study. Methods Data from 12 patients with CF and the G551D mutation prescribed ivacaftor (150 mg bd) was collected at baseline, 6, 26 and 52 weeks. The changes in symptoms of EOR were assessed by questionnaire (reflux symptom index (RSI) and Hull airway reflux questionnaire (HARQ)). Results Six patients presented EOR at baseline (RSI > 13; median 13; range 2–29) and 5 presented airway reflux (HARQ > 13; median 12; range 3 to 33). Treatment with ivacaftor was associated with a significant reduction of EOR symptoms (P
Citation
Zeybel, G. L., Pearson, J. P., Krishnan, A., Bourke, S. J., Doe, S., Anderson, A., Faruqi, S., Morice, A. H., Jones, R., McDonnell, M., Zeybel, M., Dettmar, P. W., Brodlie, M., & Ward, C. (2017). Ivacaftor and symptoms of extra-oesophageal reflux in patients with cystic fibrosis and G551D mutation. Journal of Cystic Fibrosis, 16(1), 124-131. https://doi.org/10.1016/j.jcf.2016.07.004
Journal Article Type | Article |
---|---|
Acceptance Date | Jul 12, 2016 |
Online Publication Date | Jul 27, 2016 |
Publication Date | Jan 1, 2017 |
Deposit Date | May 12, 2022 |
Publicly Available Date | May 16, 2022 |
Journal | Journal of Cystic Fibrosis |
Print ISSN | 1569-1993 |
Publisher | Elsevier |
Peer Reviewed | Peer Reviewed |
Volume | 16 |
Issue | 1 |
Pages | 124-131 |
DOI | https://doi.org/10.1016/j.jcf.2016.07.004 |
Keywords | G551D; CFTR potentiator; Gastrointestinal; Real life data |
Public URL | https://hull-repository.worktribe.com/output/3609850 |
Files
Published article
(484 Kb)
PDF
Publisher Licence URL
http://creativecommons.org/licenses/by/4.0
Copyright Statement
/© 2016 The Authors. Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
You might also like
A survey of UK respiratory specialists’ opinion on the management of chronic cough
(2024)
Journal Article
Chronic cough: symptom, sign or disease?
(2024)
Journal Article
Downloadable Citations
About Repository@Hull
Administrator e-mail: repository@hull.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search